Global mAb Biosimilars Industrial and Market studies 2016-2020
"Global
mAb Biosimilars Market 2016-2020"
The Report covers current Market Trends, Worldwide Analysis, Global
Forecast, Review, Share, Size, Growth, Effect.
Description-
About
Biosimilars
Biosimilars
or follow-on biologics are generic versions of the biopharmaceutical
products. These are developed following the patent expiry of an
original molecule. Biosimilars have the same biological properties as
original drugs and target the same diseases. They have many
similarities but are not identical to the reference biopharmaceutical
product.
Technavios
analysts forecast the spending on the global monoclonal antibody
(mAb) biosimilars market to grow at a CAGR of 4-7% during the period
2015-2020.
Covered
in this report
The
report covers the present scenario and the growth prospects of the
global monoclonal antibody (mAb) biosimilars market 2016-2020. To
calculate the market size, the report considers the report considers
the revenue generated from the sales of mAbs. The report also
considers the revenues generated from the sales of drugs that are
expected to be launched during the forecast period.
The
market is divided into the following segments based on geography:
Europe
Asia
ROW
Technavio's
report, Global Monoclonal Antibody (mAb) Biosimilars Market
2016-2020, has been prepared based on an in-depth market analysis
with inputs from industry experts. The report covers the market
landscape and its growth prospects over the coming years. The report
also includes a discussion of the key vendors operating in this
market.
Key
vendors
Biocon
Celltrion
Dr.
Reddy's Laboratories
Hospira
Other
prominent vendors
3SBio
Accord
Healthcare
AET
Biotech
Allergan
Alvartis
Pharma
Amega
Biotech
Amgen
Apotex
Aspen
AstraZeneca
Aurobindo
Pharma
Baxter
Bharat
Serums
Bio
Sidus
Biogen
Bionovis
Bioton
BioXpress
Therapeutics
Boehringer
Ingelheim
Boston
Oncology
Cipla
Coherus
Biosciences
Daiichi
Sankyo
Emcure
Pharmaceuticals
Gedeon
Richter
GeneScience
Pharmaceuticals
GSK
Hetero
Drugs
iBio
Intas
Pharmaceuticals
JCR
Pharmaceuticals
LG
Lifesciences
Lonza
Merck
Mitsubishi
Tanabe Pharma
Momenta
Pharmaceuticals
Mylan
Natco
Pharma
Novartis
Pfenex
Pfizer
Ranbaxy
Laboratories
Roche
Holding
Samsung
Biologics
Sanofi
Synthon
Market
driver
Rise
in number of patent expiries
For
a full, detailed list, view our report
Market
challenge
Physicians'
reluctance to prescribe biosimilars
For
a full, detailed list, view our report
Market
trend
Emergence
of biosimilars
For
a full, detailed list, view our report
Key
questions answered in this report
What
will the market size be in 2020 and what will the growth rate be?
What
are the key market trends?
What
is driving this market?
What
are the challenges to market growth?
Who
are the key vendors in this market space?
What
are the market opportunities and threats faced by the key vendors?
What
are the strengths and weaknesses of the key vendors?
Comments
Post a Comment